Case Studies + Testimonials

Client: Biotech / Regenerative Medicine

Objective: Assist the Company in Identifying Additional Markets for their Platform Technology

Challenge: Worked with the founders of the company concerning the future of their cryopreserved amniotic membrane technology, which at the time was the leader in a particular market but was experiencing increased competition in several others. The company needed a strategic plan and partners to grow and continue to lead while diversifying into other markets.  

Solution: A wholly-owned subsidiary was created to target orthopedics and other ancillary markets, such as burn, dental and others. Purim developed the website, physician testimonial videos, marketing strategy, and private placement. Introduced key institutional investors who put in growth capital. Purim also put together a VA hospital strategy and distribution partner that increased sales by over 30% in under 12 months.  

Outcome: Products selling globally. Revenues generated from the new subsidiary surpassed that of the original business. Company leading in multiple verticals.  

Client: Biotech / Cosmeceutical

Objective: Monetize Assets with Issued Intellectual Property

Challenge: Introduced to an ancillary product with issued IP that was a prototype but was not a core offering and sitting on a shelf. The company's focus was the ophthalmic surgeon, not the optometrist, which was the target for this plant-derived small molecule product. The company was also considering an expensive and lengthy FDA trial whereby regulatory approval and reimbursement were uncertain.  

Solution: Purim took over the commercialization program, so it was siloed and not a distraction for the main company. After considerable research, we advised pursuing a direct-to-physician path to generate revenue within 12 months vs. the uncertainty and expense of a clinical trial. Purim developed the brand, led the reengineering of the product from a complicated and faulty pen applicator to an easy-to-use wipe, validated the market, developed the messaging and marketing strategy, produced testimonial videos, developed full e-commerce and social media capabilities, and launched directly to optometrists and consumers within 11 months.  

Outcome: Increased sales 150x from the previous year at 84% gross margin with minimal overhead. Sold globally and was eventually acquired. 

----Testimonial----

"My company developed a new, interesting breakthrough medical technology for a non-core application and decided to outsource the product and market planning. This was done to allow our internal resources to focus on our fast-growing core business in regenerative medicine. As our Chief Commercialization Officer, we are now in the process of integrating the product back into our business in preparation for launch. The work that Purim has done for us is truly exceptional and rates as best in class. The product packaging is on par with the best from the top pharma companies in our space, the contract manufacturing and back-end fulfillment is in place, the promotional plans from videos to websites, including ecommerce, are poised for launch, and the pricing strategy has been developed. We had our first soft launch event in the past week in which Greg presented to an assembled crowd of over 100 physicians and at the reception we wrote orders for over 960 cartons of our new product! We are ready for market launch later this year with the pump already primed with orders. He has helped us de-risk our launch allowing us to present a product to the market worthy of our brand and reputation. I would recommend Purim for their ability to develop and deliver products to the market that will exceed your expectations." 

    Tom D.

    Chief Commercialization Officer 

    Biotechnology Company 

Client: Neuromodulation / Wearable Company  

Objective: Prepare the Company for US Market Entry  

Challenge: The company had issued IP and several antidotal use cases, but nothing performed to FDA standards which it needed to substantiate claims and ensure investor confidence.  

Solution: Purim provided strategic guidance on regulatory, quality, and raising capital. Developed marketing collateral and led the development of patient videos. Brought in several strategic investors and partners, and established a relationship with a large orthopedic research foundation, which conducted a pilot study at no cost to the client. The study was pivotal to the company raising funds and strategic partner discussions. Purim also helped establish the US distribution company that served as the model for global efforts.  

Outcome: The technology is currently waiting FDA clearance.